News
Johnson & Johnson announces a lead vaccine candidate for COVID-19
Johnson & Johnson and BARDA together commit more than$1 Billionto Novel Coronavirus Vaccine Research and Development; company expects to initiate phase 1 human clinical studies of vaccine candidate at latest by September 2020
Intas donates two million tablets of hydroxychloroquine for global trials against COVID19
Intas Pharmaceuticals has donated up to two million tablets of hydroxychloroquine to enable the largest interventional COVID-19 trial in the world involving up to 40,000 frontline healthcare workers
